COMMUNIQUÉS West-GlobeNewswire

Strongbridge Biopharma plc Added to the Russell 3000® and Microcap® Indexes
01/07/2019
DUBLIN, Ireland and TREVOSE, Pa., July 01, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]
Organogenesis Joins Russell 2000®, Russell 3000® and Russell Microcap® Indexes
01/07/2019
CANTON, Mass., July 01, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for [...]
Biogen Announces New Data Further Establishing SPINRAZA® (nusinersen) as a Foundation of Care in Spinal Muscular Atrophy for a Broad Range of Patients
01/07/2019
New results from the NURTURE study demonstrate that pre-symptomatic infants treated with SPINRAZA are achieving motor milestones that are unprecedented in the natural history of the disease, including 100 percent of [...]
Misonix Announces Inclusion in the Russell 2000® and 3000 Indexes
01/07/2019
FARMINGDALE, N.Y., July 01, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Zynerba Pharmaceuticals Added to Russell 2000® and 3000® Indexes
01/07/2019
DEVON, Pa., July 01, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Bestselling Author Kurt Eichenwald to Lead Inspiring Discussion about Epilepsy and his Memior, ‘A Mind Unraveled’ Thursday, July 11, at 7 p.m. at Mayfair Hotel and Spa
01/07/2019
Event sponsored by Engage Therapeutics in Collaboration with Nicklaus Children’s Hospital, First Choice Neurology, Epilepsy Florida, Advanced Pharma-Miami and the University of Miami MIAMI, July 01, 2019 (GLOBE NEWSWIRE [...]
BioCryst Appoints Megan Sniecinski Chief Business Officer
01/07/2019
RESEARCH TRIANGLE PARK, N.C., July 01, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Megan Sniecinski as chief business officer. Ms. Sniecinski joins BioCryst [...]
Agios Announces Orlando Oliveira Appointed as Senior Vice President and General Manager, International
01/07/2019
Mr. Oliveira to Lead the Build-Out of European Operations, Rest-of-World Commercial Strategy and Expected EU Launch of TIBSOVO® CAMBRIDGE, Mass., July 01, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: [...]
EyePoint Pharmaceuticals Added to Russell 3000® and 2000® Indexes
01/07/2019
WATERTOWN, Mass., July 01, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) (“Eyepoint”), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic [...]
European Commission Appoints CureVac Co-Founder & Supervisory Board Chairman, Ingmar Hoerr, to the European Innovation Council Advisory Board
01/07/2019
TÜBINGEN, Germany and BOSTON, July 01, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, congratulates CureVac co-founder and Chairman of the [...]
Axsome Therapeutics Added to Russell 3000® and Russell 2000® Indexes
01/07/2019
NEW YORK, July 01, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Quotient Limited Announces the Submission of the Initial SDS Microarray CE mark Filing for MosaiQ™
01/07/2019
JERSEY, Channel Islands, July 01, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced the submission of [...]
Amicus Therapeutics and Brammer Bio, a part of Thermo Fisher Scientific, Enter Strategic Gene Therapy Development and Manufacturing Collaboration
01/07/2019
Supports Clinical and Commercial Supply Needs for Multiple Batten Disease Programs Advances Amicus Mission to Deliver Novel Gene Therapies to Rare Disease Patients CRANBURY, N.J., July 01, 2019 (GLOBE NEWSWIRE) -- [...]
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Progenics Shareholders Vote “FOR” ALL of Progenics’ Director Nominees
01/07/2019
Glass Lewis Believes Velan’s “Fundamental Operational and Corporate Governance Case Fails to Bear Fruit” Glass Lewis Agrees the Current Settlement Offer is Fair and “Would Grant Velan Direct Board Representation Twice [...]
Axovant Appoints David Nassif as Chief Financial Officer and Expands Board of Directors
01/07/2019
-David Nassif joins executive management team as CFO, effective July 1, 2019- -Senthil Sundaram to join Axovant’s Board of Directors- BASEL, Switzerland, July 01, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. ( [...]
Share buy-back week 26/2019
01/07/2019
Announcement 1 July 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling up [...]
Cerecor Announces Positive Final Results of CERC-301 in the Treatment of Neurogenic Orthostatic Hypotension (OH)
01/07/2019
ROCKVILLE, Md., July 01, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
LHC Group Continues Commitment to Clinical Quality With Addition of Tricia Nguyen as Chief Medical Officer
01/07/2019
LAFAYETTE, La., July 01, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that Tricia Nguyen, MD, has joined the company as executive vice president and chief medical officer (CMO). Dr. Benjamin [...]
Parallax Health Sciences Announces Directive in the Company's Artificial Intelligence Program
01/07/2019
SANTA MONICA, CA, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, today announced that [...]

Pages